The retinoblastoma gene product (pRb) controls proliferation and differentiation processes in stratified epithelia. Importantly, and in contrast to other tissues, Rb deficiency does not lead to spontaneous skin tumor formation. As the cyclin-dependent kinase inhibitor p21 regulates proliferation and differentiation in the absence of pRb, we analyzed the consequences of deleting p21 in pRb-ablated stratified epithelia (hereafter pRb DEpi ;p21 À / À ). These mice display an enhancement of the phenotypic abnormalities observed in pRb DEpi animals, indicating that p21 partially compensates pRb absence. Remarkably, pRb DEpi ;p21 À / À mice show an acute skin inflammatory phenotype and develop spontaneous epithelial tumors, particularly affecting tongue and oral tissues. Biochemical analyses and transcriptome studies reveal changes affecting multiple pathways, including DNA damage and p53-dependent signaling responses. Comparative metagenomic analyses, together with the histopathological profiles, indicate that these mice constitute a faithful model for human head and neck squamous cell carcinomas. Collectively, our findings demonstrate that p21, in conjunction with pRb, has a central role in regulating multiple epithelial processes and orchestrating specific tumor suppressor functions.
INTRODUCTION
The pocket protein family (pRb, p107 and p130) has unique and overlapping roles in differentiation and cell cycle control. 1 Of them, the Rb gene is the predominant family member mutated in human tumors. This reflects the essential role of pRb in the control of the G1 to S phase transition in cell cycle. [2] [3] [4] Rb encodes a nuclear phosphoprotein that actively represses genes required for the G1-S phase transition through the formation of complexes with members of the E2F transcription factors family. 5 During normal cell cycle progression, pRb is functionally inactivated through phosphorylation by cyclin/cdk complexes. This releases the E2Fs, allowing the G1 to S phase transition. Consistent with this, forced expression of pRb in cells leads to growth arrest, and restoration of Rb function in pRb-deficient tumors suppresses tumor growth. 6 pRb inactivation is further regulated by two families of cdk inhibitors or cki that regulate the cdk kinase activity. 7, 8 Protein p21, the Cdkn1a gene product, belongs to the cki family and is a critical mediator of p53-induced cell cycle arrest. [9] [10] [11] The evidence for the tumor suppressor activity of p21 comes from the analysis of p21-deficient mice, [12] [13] [14] which display increased susceptibility upon carcinogenic treatments [15] [16] [17] [18] and also develop spontaneous tumors in aged mice. 19 Moreover, p21 deficiency aggravates the phenotype of mice with a variety of genetically engineered oncogenic alterations. [20] [21] [22] [23] [24] Interestingly, independent from its functions in cell cycle, p21 also modulates differentiation and apoptosis, through the direct association and control of several transcription factors and/or transcription coactivators, in specific cell types such as keratinocytes. [25] [26] [27] [28] [29] [30] The epidermis is a unique model to study proliferation and differentiation. Different lines of evidence suggested the involvement of the pRb pathway in epidermal homeostasis [31] [32] [33] [34] [35] and in the mouse skin carcinogenesis. 8, 24, [36] [37] [38] [39] [40] However, due to the early embryonic lethality displayed by Rb-deficient mice, [41] [42] [43] the role of Rb in mouse skin carcinogenesis has not been established until recently. We and others have used the Cre/loxP technology to inactivate Rb gene in epidermis. 44, 45 The pRb deficiency in epidermis (pRb DEpi mice) promotes increased proliferation and altered differentiation, leading to moderate epidermal hyperplasia and hyperkeratosis. 45 However, no spontaneous tumors were observed in these mice 45 unless the related gene p107 is also ablated. 46, 47 Moreover, the absence of pRb leads to reduced skin tumor development and increased rate of malignant conversion upon chemical carcinogenesis experiments. 48, 49 These effects are mainly mediated by acute induction of p53, which creates a selective pressure in the benign tumors, leading to premature p53 loss and thus malignant conversion. 48 In agreement, we found that pRb and p53 cooperate to suppress mouse epidermal tumors 50 and p107 loss reduces the p53 transcriptional functions in pRb DEpi mice. 47 Remarkably, spontaneous tumors arising in pRb DEpi ;p53 DEpi mice are highly aggressive, display early signs of chromosomal instability and high metastatic behavior. [50] [51] [52] The genomic profiling of these spontaneous tumors also reveal a significant overlap with human malignancies of multiple tissue 1 origin distinguished by poor prognosis, altered p53 status and high metastasis incidence. 53, 54 Given that (i) p21 is a bona fide transcriptional target of p53, 9, 11 (ii) the reported functional cooperation between pRb and p21, [20] [21] [22] and (iii) the involvement of p21 in epidermal homeostasis and carcinogenesis, [15] [16] [17] [18] 25, 26, 28 we sought to generate mice lacking p21 in the absence of epidermal pRb (Rb F19/F19 ;K14cre;Cdkn1a À / À , hereafter pRb DEpi ;p21 À / À mice). Importantly, and in contrast to the individual gene knockouts, pRb DEpi ;p21 À / À mice develop an skin inflammatory processes followed by spontaneous tumor development. Based on their histopathology and transcriptome analyses, these tumors resemble human head and neck squamous carcinomas.
RESULTS

Generation and epidermal characteristics of pRb
DEpi ;p21 À / À mice The absence of pRb in epidermis promotes increased proliferation and altered differentiation, but is insufficient to allow tumor development. This might indicate that other proteins may exert the functions of pRb in its absence to suppress tumorigenesis. This seems to be the case for the other pocket protein p107 but not for p130. 46, 47, 55 Importantly, these overlapping roles require in some cases the upregulation of the compensating protein. 56 In genomewide transcriptome analysis of primary pRb
DEpi keratinocytes and epidermis we have previously observed a clear induction of the Cdkn1a gene. 46, 55 This is also observed at the protein level ( Figure 1a ). This induction suggests that an active pathway involving this cki may limit the growth of pRb-deleted in epidermis as previously reported in other systems. [20] [21] [22] To confirm this hypothesis, pRb DEpi mice were bred with p21-deficient mice 12 to generate double-deficient mice. These mice (pRb DEpi ;p21 À / À ), in an enriched FVB background, were obtained at the expected Mendelian ratio. However soon after birth, mutant animals developed a characteristic phenotype that included reduced size, frail appearance, scaliness (hyperkeratosis) and a very sparse hair coat (Figure 1b-d) . The hair loss was more evident in the face and snout (Figure 1c) . We also noticed the presence of spontaneous wounds (Figure 1d ).
Compared with Rb F/F as control mice 45 (Figure 1e ), the epidermis of mice lacking p21 (Figure 1f ) was indistinguishable and displayed no significant abnormalities, in agreement with our previous observations. 24 In contrast, the epidermis of mice bearing specific Rb ablation displayed mild hyperplasia (increased number of cell layers) and hyperkeratosis (thickening of the stratum corneum) (Figure 1g 45 ). These alterations become clearly aggravated by the simultaneous loss of Cdkn1a gene (Figure 1h ).
The pRb
DEpi ;p21 À / À mouse epidermis showed severe hyperplasia and hyperkeratosis. By post natal day (pnd) 30, we also observed inflammatory infiltrates (Figure 1h 0 ), epithelial pustules (microabscesses denoted by an arrow in Supplementary Figure S1A ) and parakeratosis (presence of nucleated cells in the stratum corneum, indicating altered terminal differentiation, denoted by arrows in the inset of Figure 1h 0 ). The analysis of several differentiation markers confirmed these alterations, with expanded keratin K5 expression, keratin K10 expression confined to uppermost cell layers and also massive expression of keratin K6 in the interfollicular epidermis (Figure 1l and l 0 ). All these characteristics were dramatically aggravated as compared with pRb DEpi (Figure 1k and k') or p21-deficient epidermis (Figure 1j and j 0 ), which in turn is undistinguishable from control mice (Figure 1i and i 0 ). The specific ablation of pRb in epidermis results in increased proliferation in the basal layer and also in aberrant proliferation in suprabasal layers. 45 We thus investigated whether the subsequent loss of p21 also aggravates this effect. Analysis of BrdU incorporation in control (Figure 2a (Figure 2d and f) skin demonstrated significantly increased proliferation in the basal epidermal layer of double-deficient mice. Notably, the proliferation in the suprabasal layers, characteristic of pRb DEpi epidermis, was also significantly increased in pRb DEpi ;p21 À / À mice (Figure 2e and g ). Increased proliferation was accompanied by increased E2F activity as measured by luciferase experiments in primary keratinocytes (Figure 2h ), likely as a result of the increased E2F1 protein levels observed (Figure 1a) . Finally, we also analyzed whether the disengagement between proliferation and differentiation processes, which is characteristic of pRb DEpi mouse keratinocytes, was also aggravated in pRb DEpi ;p21 À / À cells. The proliferation of primary keratinocytes was analyzed at different time points upon differentiation induction by increasing the calcium concentration in the culture medium. 45 In agreement with our previous observations, 45 the absence of pRb caused a delay in the cell cycle arrest compared with control or p21 À / À cells; however, by 48-72 h in high calcium, control, p21 À / À and pRb DEpi keratinocytes displayed no significant BrdU incorporation, while in pRb DEpi ;p21 À / À a considerable number of cells still proliferate (Figure 2i) . Moreover, when terminally differentiated control cells where re-stimulated by decreasing calcium, they were unable to re-enter cell cycle, whereas pRb DEpi and pRb
DEpi
;p21 À / À , and to a minor extent p21À / À cells, displayed rates of proliferation close to those observed in nondifferentiated cells (Figure 2i ).
These results demonstrate that, whereas the loss of p21 causes minor epidermal defects by itself, it leads to an important aggravation of the phenotype generated by the epidermalspecific ablation of Rb gene producing severe gross skin alterations affecting proliferation and differentiation of the epidermal cells.
Inflammatory processes in pRb
DEpi ;p21 À / À mouse skin ;p21 À / À displayed large numbers of lymphocytes, macrophages, mastocytes and gdT cells (Figure 3a 000 -d 000 and Supplementary Figure S1E ). Of note, such inflammatory events were not detected in newborn skin (Supplementary Figure S2) The inflammatory processes in skin are associated with increased NFkB and Stat3 signaling and the production of specific cytokines. 57 To monitor whether these pathways are affected in pRb DEpi ;p21 À / À prior to overt inflammatory events, we studied the expression of key elements of these signaling pathways in newborn skin samples by western Next we analyzed, using an antibody array, the expression of several cytokines. As the loss of p21 is generalized (that is, also Suppression of inflammation and tumorigenesis by p21 C Saiz-Ladera et al affects the possible inflammatory cells) and several of these cytokines were also produced by inflammatory cells, we included in the analysis protein extract of epidermis of pnd 30 from all genotypes, newborn pRb DEpi ;p21 À / À mouse epidermis (without inflammatory signs) and from grafts of newborn pRb DEpi ;p21 À / À mouse epidermis on NOD/SCID mice after 3 months of transplantation. Notably, we noticed the increased presence of inflammatory cells in these grafts (Figure 3f-f 000 ), in spite of the immunodeficiency of the host. This probably indicates that these immune cells were already present in the newborn grafted skin, which did not show evidences of inflammation, and they proliferated and survived throughout the entire transplant span. Examples of antibody cytokine array are provided in Figure 4a . The quantitative analysis of the experiments (Figure 4b) showed, in comparison with control, p21 À / À and pRb DEpi skin extracts, the increased protein levels of GCSF, GMCSF, IL16, CXCL1, CCL3, CXCL2 and TREM1, and the decrease in the levels of CCL1 and CXCL9 in pRb DEpi ; p21 À / À extracts. However, their relative protein levels varied among adult mice (all the above commented changes), newborn (upregulation of GMCSF, CXCL1 and TREM1 
and keratin K10 (in green) by pnd 30. Yellow staining indicates co-expression. Bars ¼ 100 mm.
and repression of CXCL9 and CCL1) and grafted skin (upregulation of GCSF, GMCSF, IL16, CXCL1, CXCL2, TREM1 and repression of CXCL9 and CCL1). The comparative analysis of these three situations (overt inflammatory state in pRb DEpi ;p21 À / À mouse epidermis by pnd 30, no inflammation in newborn pRb DEpi ; p21 À / À mouse epidermis and skin grafts) indicate that the upregulation of GMCSF, CXCL1 and TREM1 and repression of CXCL9 and CCL1 is probably mediated by the epidermal Suppression of inflammation and tumorigenesis by p21 C Saiz-Ladera et al keratinocytes rather than being exclusively produced by the inflammatory cells recruited to the skin. Regarding the specific changes, we detected that cytokines responsible for the recruitment of macrophages (GMCSF) and neutrophils (CXCL1) were particularly increased. Remarkably, CXCL1 has been shown to promote epidermal wound healing and also squamous tumor development. 58 We also detected a significant increase of the inflammatory response enhancer (TREM1), which is upregulated in tumor-associated macrophages, 59 and the reduction of CXCL9, a chemoattractant of peripheral blood lymphocytes and NK cells, with anti-angiogenic activity. 60 
Development of spontaneous tumors in pRb
DEpi ;p21 À / À mice Progressive weakening and reduced survival in doubly deficient mice were observed. We thus carried out full necropsies in a large cohort of mice of the different genotypes. Upon examination of sections of various tissues, multiple spontaneous tumors were found (Table 1) . No spontaneous tumors were observed in control or pRb DEpi mice (n ¼ 50 of each) in agreement with our previous data. 45 In p21 À / À mice, we observed a reduced tumor incidence (4/44 mice), which, as reported, 19 only occurred in aged mice (48-52 weeks of age). On the contrary, we found a very high tumor incidence in pRb DEpi ;p21 À / À mice (39/44 mice, including 5 mice killed by 2-5 weeks, showing no macroscopic growth). These tumors were exclusively of stratified epithelial origin and predominantly correspond to squamous cell carcinomas (SCCs) ( Table 1) . Tumors were first observed by 2 weeks of age and the vast majority of the mice studied displayed tumors by 40 weeks (Figure 5a ). This spontaneous tumor development in pRb DEpi ;p21 À / À mice could reduce the viability of these mice. Of a particular relevance, we found that 21 of the 44 pRb DEpi ; p21 À / À mice analyzed displayed SCCs in the tongue, detected as white overgrowths affecting primarily the dorsolateral areas ( Figure 5b and b' ), which also showed massive gdT cell infiltration (Figure 5c ). Moreover, and contrary to all the other genotypes (Figure 5d ), three out of five transplants generated with pRb DEpi ;p21 À / À skin evolved to form outgrowths suggestive of tumor formation (Figure 5e ). Histology analyses confirmed that they correspond to papillomatous lesions and well-differentiated SCCs (Figure 5f ) characterized by high grade of differentiation and increased proliferation (Figure 5f 0 ). In conclusion, the combination of pRb and p21 deficiency results in the spontaneous development of tumors of stratified epithelia origin. This is in contrast with the absence of tumors in mice bearing the epithelial-specific ablation of Rb gene. 45 In addition, it is worth mentioning that most of these tumors were not previously reported to occur in p21-null mice, or they appeared at very long latency, thus indicating that pRb and p21 cooperate to suppress tumor development in stratified epithelia.
Deregulated gene expression in pRb
DEpi ;p21 À / À mouse epidermis To investigate the possible molecular mechanisms underlying the aggravated phenotype, and in particular, the tumor susceptibility displayed by pRb DEpi ;p21 À / À mice, we carried out microarray analyses from whole-skin RNA of quoted genotyped newborn mice (see Supplementary Materials and methods). We found that, compared with control mouse skin, the simultaneous loss of Rb1 and Cdkn1a genes leads to the overexpression of 1445 transcripts and underexpression of 1065 transcripts (Supplementary Tables  S1 and S2 and Figure 6a ). Enrichment analysis of gene ontology terms 61 indicated that the underexpressed genes were predominantly involved in oxido-reduction and electron chain transport processes, whereas cell adhesion, cytokine-mediated signaling pathway, epithelium development and cell proliferation were the functions predominantly affected by the overexpressed genes, in line with the observed epidermal phenotype of pRb DEpi ;p21 À / À mice ( Figure 6b ). Of note, we also observed Weeks of age at which the first tumor was observed.
Suppression of inflammation and tumorigenesis by p21 C Saiz-Ladera et al that multiple genes affecting specific pathways highly relevant to epidermal homeostasis and tumorigenesis displayed deregulated expression. These included Hedgehog (Shh, Ptch1, Smo and Sfrp1), Notch (Psen1, Hey2, Heyl and Notch1) and Wnt/Sox (Wnt11, Wnt5a, Wnt2, Sox13, Sox2, Sox21, Sox5, Lgr5, Ltbp3, Msx2, Ctnnb1, Myc and Ovol1) signaling pathways. We monitored the expression of some of these genes by qRT-PCR (Supplementary Figure S4A , B and E). Furthermore, as we found deregulated expression of genes acting as activators and inhibitors of these pathways, we also monitored their relative functionality by using common readout genes. The increased expression of Gli1 (Supplementary Figure S4C) and Hes1 (Supplementary Figure S4D) supported the activation of Shh and Notch pathways in the epidermis of pRb DEpi ;p21 À / À mice. The analysis of Lgr5, Myc, Ovol1 and Axin2 (Supplementary Figure S4E) , and the determination of increased active bcatenin by western blot (Supplementary Figure S4F ) also indicated overactivation of Wnt pathway.
Next, we studied potential transcription factors involved in the observed gene deregulation. Chromatin immunoprecipitation enrichment analysis 62 revealed a potential involvement of multiple transcription factors in the upregulated and downregulated genes, including E2Fs, Trp53 and Trp63 among others (data not shown). Of note, E2Fs were predicted to bind not only upregulated but also downregulated genes, while p63 appears predominantly associated with the upregulated genes ( Figure 6c and c  0 ) . The determination of DNp63 and TAp63 isoforms by qRT-PCR revealed a significant upregulation of the DNp63 but not of the TAp63 isoform in the pRb DEpi ;p21 À / À mouse epidermis, and to a minor extent in p21 À / À mice (Figure 6d ). Regarding the E2F transcription factors, we found increased expression of activator E2Fs (E2f1 and E2f2) and also repressor E2Fs (E2f4, E2f5 and E2f7) in the epidermis of pRb DEpi ;p21 À / À newborn mice (Figure 6e ). Finally, gene set enrichment analysis 63 was used to analyze whether gene expression differences between control and pRb DEpi ;p21 À / À newborn skin display enrichment of gene sets collected from various sources (see Supplementary Materials and   methods and Supplementary Tables S3 and S4 ). Among others, we found a significant enrichment of deregulated genes in pRb DEpi ;p21 À / À with that observed in the skin of pRb DEpi ;p53 DEpi and p53 DEpi newborn mice (Table 2 and  Supplementary Table S3) , suggesting a major role of p21 in the p53-dependent signaling in epidermis. This is further reinforced by the significant overlap with other gene sets relative to p53-dependent gene expression, DNA damage and DNA repair ( Table 2 ).
DNA damage in pRb
DEpi ;p21 À / À mouse epidermis
The gene set enrichment analysis revealed a possible activation of the DNA damage response (DDR) in pRb DEpi ;p21 À / À mouse epidermis (Table 2 ). To confirm these indications, we monitored DDR in mouse skin by analyzing the expression of phosphorylated histone H2AX (gH2AX). While no significant evidences of gH2AX were observed in control, p21 À / À or pRb DEpi mouse skin (Figure 7a-c) , clear nuclear staining was observed in pRb DEpi ;p21 À / À mice 30 days after birth (Figure 7d ). Moreover, positive gH2AX was also observed in samples by 10 days after birth (Figure 7d 0 ) and in skin transplants (Figure 7d 00 ), predominantly affecting suprabasal keratinocytes, in parallel with p53 induction (Figure 7e ). Similar gH2AX induction was biochemically detected in whole-skin protein extracts (Figure 7f) . Noteworthy, the gH2AX signal in most cases covered all the nucleus, which is the pattern observed upon exposure to replication stress (RS)-generating agents such as hydroxyurea or ATR inhibitors. 64 In addition, the possible involvement of RS in the DNA damage of pRb DEpi ;p21 À / À mouse epidermis is also suggested by the predominant presence of gH2AX signal in suprabasal cells; as the cells committed in the differentiation program do not cease DNA replication due to the simultaneous absence of Rb and p21 (Figure 2e, g and i) , they could accumulate damages. Further, in agreement with the damage being of replicative origin, the biochemical analyses showed an activation of the ATR-Chk1 pathway (Figure 7g and Supplementary Figure S5) , which coordinates the response against RS. 65, 66 The RS leads to the accumulation of single-stranded DNA, which is prone to recombine and initiate genomic rearrangements. 65, 66 Importantly, the RS-damaged cells are predominantly eliminated through mitotic catastrophe rather than apoptosis, due to the presence of unreplicated chromosomes in mitosis. We thus analyzed the presence of aberrant mitosis and mitotic catastrophes in epidermal skin sections. We found these aberrancies only in pRb DEpi ;p21 À / À mouse epidermis (Supplementary Figure S6) . On the contrary, we did not detect significant apoptotic events in the skin or in tumors of pRb DEpi ;p21 À / À mice, (Supplementary Figure S6E  0 , F 0 and G) despite the increase in p53 levels in the skin or in tumoral lesions (Figure 7g and Supplementary Figure S6E and F) . Thus, and as previously shown for the activation of oncogenes, 67 concomitant depletion of Rb and p21 on the skin leads to widespread levels of RS, which activate the DDR-p53 axis.
pRb
DEpi ;p21 À / À mice represent a model of human head and neck SCC The SCC development observed in oral tissues and tongue of pRb DEpi ;p21 À / À mice might indicate that these genetically engineered mice would represent a model of HNSCC. Human head and neck SCC (HNSCC) is the sixth most common human cancer worldwide and, in spite of recent progress in therapeutic management of this disease, the improvement of overall survival Suppression of inflammation and tumorigenesis by p21 C Saiz-Ladera et al in HNSCC patients is still low. 68 Therefore, the development of animal models recapitulating the characteristics of human HNSCC would allow advances of new molecularly targeted therapies. [68] [69] [70] Moreover, our gene set enrichment analysis analysis also showed a significant overlap with previous transcriptome studies of human HNSCC (Table 2, Supplementary Tables S3 and S4) . Consequently, we aimed to validate pRb DEpi ;p21 À / À mice as a potentially suitable model of human HNSCC.
To this, we compared the genes overexpressed in pRb DEpi ;p21 À / À mice with human HNSCC transcriptome studies using the Oncomine database. 71, 72 The comparison revealed a significant overlap between overexpressed mRNAs in pRb DEpi ;p21 À / À newborn mouse epidermis with homologous mRNAs overexpressed in multiple HNSCC expression data sets (Supplementary Table S5 ). This overlapping allowed us to obtain a signature of commonly overexpressed gene both in mouse epidermis and human HNSCC studies selected (Figure 8a ). Of note, we also observed a significant overlap between the upregulated mouse genes and those downregulated in human HNSCC present in Oncomine database and characterized by increased stage, grade and metastatic likelihood, poor clinical outcome, and also in metastasis compared with primary tumors (Supplementary Table S6 ). These findings would suggest that the pRb DEpi ;p21 À / À mice might represent a faithful model of good prognosis HNSCC. To test this aspect, we monitored the mousehuman signature in a gene expression data set that contains HNSCC primary tumors with follow-up information of metastatic events 73 and shows a significant overlap by gene set enrichment analysis (Figure 8b, b 0 and c). Unsupervised sample clustering using this common gene signature identified two patient groups (Figure 8d) , with statistically significant differences in metastasisfree survival (Figure 8e) . Importantly, samples with poor clinical outcome display underexpression of the pRb DEpi ;p21 À / À signature genes, reinforcing the hypothesis that the pRb DEpi ;p21 À / À mice might represent a potential model of human HNSCC characterized by good prognosis. Importantly, human HNSCC is characterized by intense immunosuppression, 74 probably mediated by myeloid-derived suppressor cell populations. These cells are a heterogeneous population of early myeloid cells that expand as a consequence of chronic inflammation in response to proinflammatory mediators. The myeloid-derived suppressor cells are mainly found in peripheral blood and tumor tissue and to a lesser extend in lymph nodes. Phenotypically, in mouse-bearing tumors, these cells are identified by the expression of Gr-1 þ CD11b þ surface markers with subsets expressing CD49d representing the most suppressive ones. 75 We observed massive enlargement of submaxilar and inguinal lymph nodes in pRb DEpi ;p21 À / À mice (Supplementary Figure S7A) and increased levels of Gr-1 þ CD11b þ myeloid-derived suppressor cells, which also express CD49d, in peripheral blood and lymph nodes (Supplementary Figure S7B and C) . These observations parallel with the mechanism of immune evasion observed in patients with head and neck cancers. 76 Finally, our comparative study in Oncomine database revealed that upregulated genes are also present in HNSCC cell lines sensitive or resistant to specific chemotherapeutic drugs (Supplementary Table S7 ), indicating that the pRb DEpi ;p21 À / À mice could also be used as tools to test the specificity of these compounds in tumor therapy or chemoprevention.
DISCUSSION
The retinoblastoma gene plays multiple functions in cell cycle, differentiation and apoptosis. However, in contrast with the widely reported alterations in the so called pRb pathway, mutations of Rb gene are restricted to few human tumors. In agreement with these observations, mouse models reveal that the ablation of Rb does not produce the development of spontaneous tumors in a large number of tissues. This has been attributed in several instances to the functional compensation by other genes such as the Rb family members, p107 and p130. 77, 78 In mouse epidermis, pRb loss generates a characteristic phenotype but not the development of spontaneous tumors. 45 Here we show that the phenotype due to pRb loss is further aggravated by the absence of p21, affecting differentiation and proliferation and allowing spontaneous tumor development. These findings are similar to the reported Suppression of inflammation and tumorigenesis by p21 C Saiz-Ladera et al overlapping functions between pRb and p107 in this tissue, 45, 46, 56 which interestingly also led to oral and perioral spontaneous tumor development. 47 However, we also observed alterations such as epidermal parakeratosis and an exacerbated inflammatory response not observed in pRb DEpi ;p107 mice, suggesting that the compensating functions of p21 and p107 over pRb deficiency are different. These observations, together with the recently reported spontaneous tumor development mediated by E2F1 loss in pRb DEpi mice, 79 reveal complex and intricate roles of pRb and the retinoblastoma pathway components in stratified epithelia homeostasis through the interaction with other signaling pathways. In this regard, we have also observed deregulation of Wnt, Shh and Notch pathways in pRb DEpi ;p21 À / À mouse skin. The p21 protein participates in the pRb pathway through the negative modulation of cdk activity. 25 However, through the interaction with several proteins such as transcription factors and/ or transcription coactivators, it also has many functions independent of its roles in cell cycle modulation. [25] [26] [27] [28] 30 Interestingly, in certain situations, p21 can control DNA replication even in the absence of pRb, in part through its ability to interact with E2F transcription factors. 22, 80 In this regard, we have observed increased E2F activity and deregulated expression of specific E2F family members, which may partially account for the observed deregulated gene expression in pRb DEpi ;p21 À / À mouse skin. Collectively, it is thus conceivable that p21 can compensate the absence of pRb, which can explain its roles as tumor suppressor. Indeed, p21-deficient mice are prone to tumor development at advanced age, 19, 81 and its deficiency collaborates with other genetic mouse models to increase tumorigenesis. 15, 24, 82 In addition, p21 is a transcriptional target of p53, which is also able to cooperate with pRb to prevent spontaneous tumor development. 50 Of note, tumors Suppression of inflammation and tumorigenesis by p21 C Saiz-Ladera et al generated in pRb DEpi ;p53 DEpi display chromosomal instability, slight inflammation, 52 high metastatic behavior 51 and remarkable transcriptome similarities with human tumors characterized by increased malignant behavior and poor prognosis. 53, 54 The similarities in the transcriptome between pRb DEpi ;p53 DEpi and pRb DEpi ;p21 À / À mouse skin and the presence of aberrant mitosis point to a major role of p21 in mediating p53-dependent signaling in this tissue, at least in the context of pRb deficiency. However, there are important differences between pRb DEpi ;p53
DEpi and pRb DEpi ;p21 À / À mouse skin, as we did not observe aggravation of the pRb DEpi phenotype in pRb DEpi ;p53 DEpi50 , and we did not detect overt metastasis in pRb DEpi ;p21 À / À mice. The inflammatory response found in pRb DEpi ;p21 À / À mouse skin is accompanied by abundant lymphocytes, macrophages, mastocytes and gdT cells. This inflammatory phenotype is concomitant to the activation of NFkB and Stat3 signaling, two processes in which p21 has a potential role, 29 and increased production of inflammatory cytokines. This inflammatory milieu could favor tumor development, creating an environment prone to malignancy. In this regard, the pattern of cytokines observed in pRb DEpi ;p21 À / À mouse is similar to those observed in different types of tumors. [58] [59] [60] 83 For instance, human HNSCC development requires ancillary signals from inflammatory and 'tumor-educated' stromal cells that contribute to the survival, proliferation and maintenance of the undifferentiated state of transformed keratinocytes through increased expression of several cytokines. 84, 85 Rising evidence indicates that the targeting of pro-tumorigenic autocrine/paracrine loops might represent a valuable therapeutic avenue for HNSCC treatment, in part due to the immunosuppressive characteristics of this type of tumors. 74 Unfortunately, the key signaling elements of these inflammatory responses remain largely unknown.
The pRb DEpi ;p21 À / À mouse epidermis is also characterized by extensive DNA damage and the subsequent activation of DDR. 86 Given the roles of pRb and p21 in restricting S-phase entry, this is most likely due to RS, which stands for the accumulation of large patches of single-stranded DNA that are toxic due to their propensity to recombine and initiate genomic rearrangements. 65, 66 This kind of damage is also the same as the one initiated by oncogenes, which also promote a promiscuous S-phase entry. 67 In addition to restricting replicative damage, extensive DNA damage causes p21 degradation and apoptosis induction, thereby providing an independent link between DNA damage and this cki. Consistent with the known role of the DDR kinases in activating p53, mutant skin presented increased levels of this tumor suppressor, yet no evidences of apoptosis were found. Noteworthy, this could again be due to the origin of the damage being RS, which eliminates cells through mitotic catastrophe rather than apoptosis.
The tumor spectrum observed in pRb DEpi ;p21 À / À mice together with the transcriptome studies support the hypothesis of a functional role for pRb and p21 in oral tumorigenesis and in HNSCC development. Importantly, the landscape of mutations in this type of cancer has been recently reported [87] [88] [89] [90] and no mutations in RB1 or CDKN1A genes were found. However, indirect evidence may sustain this hypothesis. First, pRb is functionally inactivated in most human tumors including HNSCC, 91 probably through the amplification of CCND1 and inactivation of CDKN2A. [87] [88] [89] In addition, p53 is frequently mutated in ;p21 À / À newborn mouse skin and different clusters of the Rickman data set. 73 (d) Unsupervised sample clustering using common genes was done in Rickman data set, 73 which contains HNSCC primary tumors with follow-up information of metastatic events. Clustering gave rise to two sample groups (d), with statistically significant differences in metastasis-free survival (e). Importantly, samples with poor clinical outcome display underexpression of the pRb DEpi ;p21 À / À signature genes.
Suppression of inflammation and tumorigenesis by p21 C Saiz-Ladera et al HNSCC, [87] [88] [89] leading to altered p21 expression. 91, 92 Nonetheless, an important part of human HNSCC also displays mutations leading to impaired Notch signaling and alterations in DNp63 expression. [87] [88] [89] These findings have been associated to impaired terminal differentiation in the tumors. [87] [88] [89] We observed increased expression of DNp63 and deregulated expression of Notch pathway genes in pRb DEpi ;p21 À / À mouse epidermis. However, the increased expression of Hes1 would indicate overall activation of the Notch pathway rather than inhibition. In this regard, it is worth considering that the tumors observed in these mice were predominantly well differentiated. Moreover, part of the tumor suppressor functions of Notch in HNSCC are associated with a cell proliferation arrest mediated by p21 induction, 89 a process obviously impaired in pRb DEpi ;p21 À / À mice. The possible relevance of these deregulated signaling pathways in mice would deserve future analysis in clinical samples.
In addition, our transcriptome comparative studies also demonstrate significant similarities between deregulated genes in pRb DEpi ;p21 À / À mice and human HNSCC characterized by human papilloma virus (HPV) infection and/or good prognosis. HPV infection may induce the development of specific HNSCC subtypes associated with better clinical outcome and characterized by specific gene expression patterns. 93 These characteristics have been attributed to the expression of the two main viral oncogenes E7 and E6. 93 Importantly, the expression of viral E7 oncoprotein interferes with pRb and p21, supporting an active role of these two tumor suppressors in preventing epithelial tumors, 91, 94, 95 and HPV E6 oncogene targets p53 tumor suppressor to degradation, thus disturbing p21 expression. Nonetheless, we recently reported that, in artificial human skin prepared using primary keratinocytes engineered to express the E7 protein and engrafted onto nude mice, the expression of E7 oncoprotein produces upregulation of p21 gene while maintaining significant overlap in mRNA and miRNA expression with human HPV-associated pretumoral and tumoral lesions. Given the relevance of HPV in HNSCC development, these observations deserve future research aimed to identify the possible similarities and potential differences between pRb DEpi ;p21 À / À mouse tumors and human HPV-positive HNSCC as previously reported. 96 Altogether, the present study reveals relevant and cooperative roles of pRb and p21 in epidermis and other stratified epithelia, affecting in a cell-autonomous manner proliferation and differentiation and in a non-cell autonomous way other processes such as inflammation. The results presented here support that p21 has a key role in limiting cancer onset in the absence of a pRb pathway, and provide a valuable platform for the study of human epithelial malignancies.
MATERIALS AND METHODS
Mice and histological procedures
All mice husbandry and experimental procedures were approved by the Animal Ethical Committee (CEEA) and conducted in compliance with Centro de Investigaciones Energé ticas, Medioambientales y Tecnoló gicas (CIEMAT) guidelines. Mice were generated and identified by PCR as described. 12, 45 Samples were fixed in 4% buffered formalin or 70% ethanol, embedded in paraffin wax and sectioned (5 mm). Mice were injected with bromodeoxyuridine (BrdU; 0.1 mg/g weight in 0.9% NaCl) 1 h before being killed. Immunohistochemistry and immunofluorescence were performed using standard protocols 50, 52, 97 on deparaffinized sections using antibodies against K5, K6 (1/500 Covance), K10 (1/50 DE-K10 DakoCytomation), gH2AX Ser 139 (Upstate), cleaved caspase 3 (1/50, Cell Signaling), gd T-cell receptor-FITC (gd TCR-FITC) (1/50, BD Pharmingen), Biotin-CD45 (1/50, Pharmingen), F480 (against macrophages, 1/50 Abcam, Cl: A3-1) and CD3 e (against T cells and NK cells, 1/6 DakoCytomation). Mast cells detection was done using Toluidine blue stain, taking advantage of metachromasia properties of these cells (Certistain). BrdU incorporation was monitored as described. 98, 99 Secondary antibodies were purchased from Jackson Immunoresearch Laboratory. Control slides were obtained by replacing the primary antibodies with PBS (data not shown). Immunofluorescences were counterstained with DAPI (1/100, Roche).
Cell culture and luciferase assays
Primary keratinocytes cultures and E2F luciferase assays were performed as previously reported 98,99 using pSV40-Renilla (Promega) and pE2F-Luc (Dr X Lu, Ludwig Institute, London, UK). Two independent transfection experiments (performed in triplicate) were carried out and luciferase activity was normalized to the values obtained with control (RbF/F) cells.
Western blot analysis
Skin and primary keratinocyte extracts were obtained as reported. 98, 99 Total protein (50 mg) was used for SDS-PAGE, transferred to nitrocelullose (Amersham) and probed with primary antibodies (diluted 1/500) against pRb, p107, p130, E2F1 (Santa Cruz), p21 (Abcam), p53 (Novocastra), phospho Tyr-705 Stat3, Stat3, phospho Ser 536 p65 (Cell Signaling), ATR (Serotec), phospho Ser345-Chk1, Caspase 3, Parp (Cell Signaling) (diluted 1/ 200); active bcatenin (Millipore) (diluted 1/500); p65, IkB-a, Ikk-g (Santa Cruz); (diluted 1/2000) Ikk-a, and (1/1000) IKK-b (Imgenex), gH2AX Ser 139 (Upstate), Chk1 (Novocastra) and (1/5000) H2AX (Abcam). Actin (1/500, Santa Cruz) was used to normalize the loading. Chemiluminescence was performed using manufacturer's recommendations (Pierce) .
The cytokines panel was analyzed following manufacturer's recommendations (Proteome Profiler Mouse Cytokine, R&D Systems, ARY006). Membranes were incubated with 1 mg of pnd 30 protein extracts from skin of pRb DEpi , p21 À / À , pRb DEpi ;p21 À / À or Rb F/F (as a control) and from newborn pRb DEpi ;p21 À / À mouse epidermis after 3 months upon grafting onto NOD/SCID mice. This array screens for relative levels of 40 different cytokines and chemokines. Quantification of the relative expression was determined by QuantityOne software.
Mouse skin grafts
Skin grafting was performed following previous protocols. 46, 100 Briefly, dorsal full-thickness skin pieces of 2 cm 2 were obtained from pRb DEpi , p21 À / À , pRb DEpi ;p21 À / À or Rb F/F (as a control) newborn mice (2 days after birth). Donor skin pieces were grafted onto a wound created by removing a similar-sized piece of full-thickness back skin from female immunodeficient NOD/SCID recipient mice, as previously described. 100 Graft-recipient animals were routinely monitored for tumors and killed 12 weeks after grafting.
